Based on interview and record review, the facility failed to ensure an as needed psychotropic medication was limited to 14 days, unless the rationale for continuing the medication was documented by a medical provider, for 1 (#2) of 17 sampled residents. Findings include:Review of resident #2's medication administration record, dated 1/1/26 through 4/30/26, showed an order for alprazolam 0.25 mg, take two tablets, twice daily, as needed for anxiety.Review of resident #2's medication administration record, dated 5/1/26 through 5/19/26, showed an order for alprazolam 0.5 mg one tablet daily, as needed for anxiety.Both of resident #2's psychotropic medication orders for alprazolam did not include an end or stop date, and were not limited to 14 days.During an interview on 5/26/26 at 3:30 p.m.,… …
F605 citations in Montana
Freedom from Abuse, Neglect, and Exploitation Deficiencies
Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.
Against expectation — 2025
Montana cites F605 less often than its own record predicts
0.89 times the national share — cited less often here than elsewhere.
Of every deficiency written in Montana in 2025, this is the portion that was F605.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Montana surveyors wrote
F605 findings written in Montana, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
What else Montana surveyors cite →
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction